drugset / Trial / NCT00051688
Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
Treatment
Summary
The primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate tumor response to the combination of anti-cancer drugs.
Timeline
- Start
- 2003-06
- Primary completion
- —
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxaliplatin | Small molecule | — | — |
| Subject | TEZACITABINE ANHYDROUS | Other / unclassified | — | — |